Inhibitors of receptor interacting protein kinase I for the treatment of disease
US11690850B2 · kind B2 · utility
2Cited by
1References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2020 |
| Grant date | Jul 4, 2023 |
| Priority date | — |
| Expiry date | Apr 6, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.